# A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder

> **NCT05103657** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 318 (actual)

## Conditions studied

- Post-Traumatic Stress Disorder

## Interventions

- **DRUG:** BI 1358894
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05103657
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-07
- **Primary completion:** 2023-10-12
- **Final completion:** 2023-11-20
- **Target enrollment:** 318 (ACTUAL)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05103657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05103657, "A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05103657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*